{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:21:00Z","timestamp":1723594860723},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jvacx.2024.100508","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T11:21:26Z","timestamp":1717672886000},"page":"100508","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impacts of COVID-19 vaccine boosters on clinical outcomes associated with the Omicron variant in China: A cross-sectional survey"],"prefix":"10.1016","volume":"19","author":[{"given":"Haisu","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiatong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvacx.2024.100508_b0005","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2107715","article-title":"Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile","volume":"385","author":"Jara","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvacx.2024.100508_b0010","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijid.2021.11.009","article-title":"Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis","volume":"114","author":"Zheng","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100508_b0015","first-page":"9","article-title":"COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective. Open Forum","author":"Marcelin","year":"2022","journal-title":"Infect Dis"},{"issue":"457\u2013466","key":"10.1016\/j.jvacx.2024.100508_b0020","first-page":"e4","article-title":"mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant","volume":"185","author":"Garcia-Beltran","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jvacx.2024.100508_b0025","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S2213-2600(22)00042-X","article-title":"Comparative vaccine effectiveness against severe COVID-19 over time in US hospital administrative data: a case-control study","volume":"10","author":"Wright","year":"2022","journal-title":"Lancet Respiratory Medicine"},{"key":"10.1016\/j.jvacx.2024.100508_b0030","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1473-3099(21)00681-2","article-title":"Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials","volume":"22","author":"Zeng","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100508_b0035","doi-asserted-by":"crossref","first-page":"e067873","DOI":"10.1136\/bmj-2021-067873","article-title":"Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study","volume":"375","author":"Israel","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jvacx.2024.100508_b0040","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1056\/NEJMoa2114228","article-title":"Waning Immunity after the BNT162b2 Vaccine in Israel","volume":"385","author":"Goldberg","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvacx.2024.100508_b0045","unstructured":"National epidemic situation of COVID-19 infection . 2023. https:\/\/www.chinacdc.cn\/jkzt\/crb\/zl\/szkb_11803\/jszl_13141\/202301\/t20230125_263519.html."},{"key":"10.1016\/j.jvacx.2024.100508_b0050","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S0140-6736(22)00327-0","article-title":"Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study","volume":"399","author":"Menni","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jvacx.2024.100508_b0055","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1080\/02664763.2017.1322559","article-title":"On a tobit\u2013Birnbaum\u2013Saunders model with an application to medical data","volume":"45","author":"Desousa","year":"2017","journal-title":"J Appl Stat"},{"key":"10.1016\/j.jvacx.2024.100508_b0060","first-page":"374","article-title":"Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study","author":"Ranzani","year":"2021","journal-title":"Bmj-British Medical Journal"},{"key":"10.1016\/j.jvacx.2024.100508_b0065","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting","volume":"384","author":"Dagan","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvacx.2024.100508_b0070","first-page":"10","article-title":"The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis. Front","author":"Zou","year":"2022","journal-title":"Public Health"},{"key":"10.1016\/j.jvacx.2024.100508_b0075","first-page":"13","article-title":"Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study)","author":"Kiss","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jvacx.2024.100508_b0080","first-page":"14","article-title":"Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study","author":"He","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jvacx.2024.100508_b0085","first-page":"11","article-title":"Inactivated vaccine effectiveness against symptomatic COVID-19 in Fujian, China during the Omicron BA.2 outbreak. Front","author":"Ye","year":"2023","journal-title":"Public Health"},{"key":"10.1016\/j.jvacx.2024.100508_b0090","first-page":"12","article-title":"Vaccination effects on post-infection outcomes in the Omicron BA.2 outbreak in Shanghai. Emerg","author":"Wu","year":"2023","journal-title":"Microbes Infect"},{"key":"10.1016\/j.jvacx.2024.100508_b0095","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/infdis\/jiac360","article-title":"Effectiveness of CoronaVac and BNT162b2 Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.2 Infections in Hong Kong","volume":"226","author":"Yang","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100508_b0100","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.2147\/RMHP.S311074","article-title":"The Willingness to Receive COVID-19 Vaccine and Its Associated Factors: \u201cVaccination Refusal Could Prolong the War of This Pandemic\u201d - A Systematic Review","volume":"14","author":"Wake","year":"2021","journal-title":"Risk Manag Healthc Policy"},{"key":"10.1016\/j.jvacx.2024.100508_b0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ajim.23199","article-title":"Estimation of differential occupational risk of COVID-19 by comparing risk factors with case data by occupational group","volume":"64","author":"Zhang","year":"2021","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.jvacx.2024.100508_b0110","unstructured":"National epidemic situation of COVID-19 infection . 2023. https:\/\/www.chinacdc.cn\/jkzt\/crb\/zl\/szkb_11803\/jszl_13141\/202303\/t20230311_264174.html (accessed April 18, 2024)."}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224000810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224000810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T03:43:34Z","timestamp":1723520614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136224000810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":22,"alternative-id":["S2590136224000810"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100508","relation":{},"ISSN":["2590-1362"],"issn-type":[{"type":"print","value":"2590-1362"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impacts of COVID-19 vaccine boosters on clinical outcomes associated with the Omicron variant in China: A cross-sectional survey","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100508"}}